Remove 2025 Remove Drug Development Remove Prescription Filling
article thumbnail

NHC Comments on Response to the Medicare Program; Request for Information on Medicare Advantage Data

Putting Patients First Blog

Prior authorization and association with delayed or discontinued prescription fills. NHC comments on draft CY 2025 Part D redesign program instructions. Retrieved from [link] Comments-RE-Draft-CY-2025-Part-D-Redesign-Program-Instructions.pdf 15 National Health Council. and Keating, N. Journal of Clinical Oncology, 42(8).

article thumbnail

January 2025 Newsletter

Safe Biologics

The consequences of the IRAs small molecule penalty, which limits the time manufacturers have to recoup investments in simpler small molecule drugs like pills, are already being felt. Small molecule drugs make up over 90% of prescriptions filled in the U.S. PBM Reform: Could 2025 Finally See a Long-Awaited Overhaul?